🩻MSK🩻 - Lupus Flashcards

1
Q

What are the autoimmune connective tissue disorders?

A

SLE
Sjogren’s syndrome
Systemic sclerosis (scleroderma)
Autoimmune inflammatory muscle disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is SLE?

A

Autoimmune disease involving disturbance of both innate and adaptive immune systems
Autoantibodies to nuclear components
Antibody-antigen (immune complexes) & other mechanisms -> chronic tissue inflammation
Multi-site inflammation but particularly the joints, skin and kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What features are characteristic of autoimmune connective tissue disorders in general?

A

Arthralgia and non-erosive arthritis
Serum autoantibodies - useful diagnostically, corelates with disease activity, may be directly pathogenic
Raynaud’s phenomenon - intermittent vasospasm of digits - usually triggered by cold exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline Raynaud’s

A

Intermittent vasospasm of digits
Usually triggered by cold exposure
Typical triphasic colour changes - white, blue, red
Severe Raynaud’s -> tissue ischaemia, ulcers and necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the epidemiology of SLE?

A

Typical onset between 15 – 45 years
F:M ~9:1
Prevalence and severity varies by ancestry
African > Asian > White European
Clinical manifestations highly variable
Disease can range from mild to life threatening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is there so much variety in SLE presentations?

A

Target of autoantibodies are nuclear components - present in just about every cell
Such a wide variety of potential targets = a huge variety of outcomes and presentations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do finger deformities in SLE differ from those in types of arthritis?

A

SLE-induced deformities show no bony erosions - deformity is due purely to soft tissue damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some of the clinical features of SLE?

A

Skin and mucosa - malar rash, photosensitive rash, mouth ulcers, hair loss
Vascular - Raynaud’s
MSK - Arthralgia and (non-erosive)
Internal organs - serositis (pericarditis, pleuritis etc…), renal disease, cerebral disease, myocarditis
Haematological - autoimmune thrombocytopenia, haemolytic anaemia
Other - lymphadenopathy, fever with no infection
Can be any combination of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What marker is a hallmark of SLE?

A

Presence of ANA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is ANA?

A

Anti-nuclear antibodies
Found in all SLE patients (actually some don’t but for the purposes of the exams assume they all do)
Negative ANA rules out SLE, positive doesn’t diagnose however - may be seen in other autoimmune diseases, infections or even sometimes healthy people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is done after ANA are identified?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is APL?

A

Antiphospholipid (APL) antibodies
As well as ANA, some SLE patients have antibodies directed to phospholipids on cell membrane
`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the presence of APL antibodies associated with?

A

Increased risk of thrombosis:
Arterial - stroke
Venous - DVT

Pregnancy loss - miscarriage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is anti-phospholipid antibody syndrome?

A

Persistent presence of APL + a clinical event
Anti-phospholipid antibody syndrome can also occur in absence of SLE
(‘primary anti-phospholipid antibody syndrome’ )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What other autoantibodies are specific for SLE?

A

Anti-double stranded DNA antibodies (anti-dsDNA) - serum level correlates with disease activity
Anti-Sm antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What autoantibodies are associated with RA?

A

Rheumatoid Factor
Anti-cyclic citrullinated peptide antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What autoantibodies are associated with SLE?

A

Antinuclear antibodies (ANA)
Anti-double stranded DNA antibodies (anti-dsDNA)
Anti-phospholipid antibodies
Anti-Smith

Anti-Ro
Anti-La
Anti-RNP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which of SLE’s immunopathogeneses stem from innate immunity?

A

Overactivity of type 1 interferon pathway
Complement pathway abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which of SLE’s immunopathogeneses stem from adaptive immunity?

A

Autoreactive T and B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is the immune system generating a response to nuclear antigens?
(should be hidden inside the cell)

A

the ‘waste disposal hypothesis’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What types of investigations would you do for SLE?

A

Inflammation
Haematology
Renal
Immunological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What inflammatory markers would their be in SLE?

A

High ESR
Normal CRP (unless infection or serositis/arthritis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What might you find in haematological investigations in a patient with SLE?

A

Haemolytic anaemia
Lymphopenia
Thrombocytopenia

24
Q

What renal signs might you see in SLE?

A

Urine protein - VERY IMPORTANT
Creatinine
Look at albumin
Kidney biopsy if persistent proteinuria

25
Q

What immunological signs might be apparent upon investigation in SLE?

A

ANA
Anti-dsDNA
Low complement (i.e. low C4 and C3) - complement used in immune complexes
APL antibodies

26
Q

How can SLE activity be measured?

A

Combination of clinical signs/symptoms and investigations
Unwell Patient with active lupus typically has:
Low complement C3 and C4 levels
High anti-dsDNA antibodies

27
Q

How can a platelet count be used to measure activity of SLE?

A

Thrombocytopenia = more active disease
More autoimmune destruction of platelets

28
Q

What is the overall aim of SLE treatment?

A

Remission/low disease activity
Prevention of flares

29
Q

What must be carefully balanced in SLE treatment?

A

Controlling disease vs avoiding iatrogenic harm (especially steroids)

30
Q

What iatrogenic harm can potentially be caused by SLE?

A

Infection
Osteoporosis
Avascular necrosis (AVN) - often affects hips. Higher incidence in lupus, ++ in presence of APL antibodies

31
Q

What is used to decide upon the specific choice of treatment in SLE?

A

Disease severity
Organ involvement/manifestations

32
Q

What can be used to expedite the tapering/discontinuation of glucocorticoids in SLE?

A

Appropriate initiation of immunomodulatory agents

33
Q

What are the most commonly used pharmacological options in SLE management?

A

Hydroxychloroquine is recommended in all SLE patients
Steroids for acute flares - withdraw ASAP

34
Q

What is given for mild SLE?

A

Hydroxychloroquine alone may be sufficient

35
Q

What is given in more serious SLE?

A

Hydroxychloroquine + immunomodulatory agents
(mycophenolate, methotrexate, azathioprine)

36
Q

What is given in SLE with renal disease?

A

Mycophenolate +/- rituximab

37
Q

What is given in persistently active SLE?

A

B cell targeted therapies
Rituximab = anti-CD20 monoclonal antibody: depletes B cells
Belimumab = anti-BAFF antibody (BAFF = a B cell survival factor/cytokine)

38
Q

What is given in severe/life-threatening SLE (e.g. SLE featuring myocarditis)?

A

iv steroids + iv cyclophosphamide (+/- rituximab)

39
Q

How is an SLE patient identified to have antiphospholipid antibody syndrome?

A

An episode of clot
APL abs positive

40
Q

What should a patient with SLE and antiphospholipid antibody syndrome receive?

A

Anticoagulants (e.g. warfarin)

41
Q

What is anifrolumab?

A

Emerging therapy
Interferon receptor blockade

42
Q

What must be considered with SLE and pregnancy?

A

Risk of disease and drugs to both mother and foetus

43
Q

How are the best outcomes achieved with SLE and pregnancy?

A

Get SLE into remission before pregnancy
Pre-pregnancy planning

44
Q

What is a specific consideration for APL abs and pregnancy?

A

Associated with miscarriage
Reduce risk with aspirin/heparin

45
Q

What must be considered with pregnancy and SLE in terms of kidney function?

A

Pregnancy increases haemodynamic demands - will worsen renal function

46
Q

Other than APL, what is another risk to the foetus in SLE pregnancies?

A

Ro antibodies - can cause foetal heartblock

47
Q

What drug considerations must be taken into account with pregnancy in SLE?

A

MMF, cyclophosphamide, methotrexate, warfarin are teratogenic - high risk of severe foetal damage/deformity

Hydroxychloroquine, azathioprine, low molecular weight heparin (LMWH) are safe

48
Q

(not in exam)
What is Sjogren’s syndrome?

A

Autoimmune exocrinopathy
lymphocytic infiltration of exocrine glands (lacrimal and salivary glands)
Exocrine gland pathology results in
Dry eyes (xerophthalmia)
Dry mouth (xerostomia)
Parotid gland enlargement

49
Q

(not in exam)
What are the extra-glandular manifestations of Sjogren’s?

A

non-erosive arthritis
Raynaud’s phenomenon
pleural effusion
autoimmune hepatitis

50
Q

(not in exam)
What is the autoantibody profile of Sjogren’s?

A

Ro+, La+. RF often +
CCP -

51
Q

(not in exam)
What is inflammatory muscle disease?

A

Dermatomyositis = muscle & skin inflammation
Polymyositis - (muscle only, no rash)

52
Q

(not in exam)
What are the skin changes in dermatomyositis?

A

Lilac-coloured (heliotrope) rash on eyelids, malar region and naso-labial folds
Red or purple flat or raised lesions on knuckles (Gottron’s papules

53
Q

(not in exam)
What are the investigations for inflammatory muscle disease?

A

Bloods - Elevated creatine kinase (CK)
Electromyography
Muscle biopsy (polymyositis - CD8 T cell infiltrate, ; dermatomyositis - CD4 T cells in addition to B cells)

54
Q

(not in exam)
Which other pathologies/diseases are strongly associated with inflammatory muscle disease?

A

Malignancy (10-15%)
Pulmonary fibrosis

55
Q

(not in exam)
What is systemic sclerosis (scleroderma)?

A

Thickened skin with Raynaud’s phenomenon
dermal fibrosis
cutaneous calcinosis
telangiectasia

56
Q

(not in exam)
What are the 2 main categories of scleroderma?

A

Skin changes may be limited or diffuse

Limited systemic sclerosis:
Fibrotic skin limited to hands, forearms, feet, neck and face
Anti-centromere antibodies
Pulmonary hypertension
Long history of Raynaud’s phenomenon

Diffuse systemic sclerosis:
Fibrotic skin proximal to elbows or knees (excluding face and neck)
Anti-Scl-70 antibodies
Pulmonary fibrosis, renal (thrombotic microangiopathy) involvement
Short history of Raynaud’s phenomenon